1 Charles PJ Smeenk RJ De Jong J Feldman M Maini RN . Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum2000; 43: 2383–2390.
2.
2 Casciola-Rosen LA Anhalt G Rosen A . Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med1994; 179: 1317–1330.
3.
3 Gewurtz H Zhang XH Lint TF . Structure and function of the pentraxins. Curr Opin Immunol1995; 7: 54–64.
4.
4 Bicerstaff MC Botto M Huntchinson WL . Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med1999; 5: 694–697.
5.
5 De Brandt M Sibilia J Le Loet X . Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther2005; 7: R445–R451.
6.
6 Ramos-Casals M Brito-Zerón P Munoz S . Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore)2007; 86: 242–251.
7.
7 Aringer M Graninger WB Steiner G Smolen JS . Safety and efficacy of tumor necrosis factor alfa blockade in systemic lupus erythematosus. Arthritis Rheum2004; 50: 3161–3169.
